Benitec Biopharma Ltd (NASDAQ:BNTC)

2.06
Delayed Data
As of 3:53pm ET
 0.00 / 0.00%
Today’s Change
1.85
Today|||52-Week Range
4.19
-30.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues254.1K255.7K179.7K251.1K
 
 
 
 
 
Cost of Goods Sold--2.9M4.7M4.0M
 
 
 
 
Depreciation And Amortization11.8K80.8K211.0K163.7K
 
 
 
 
 
 
Operating ExpensesGross Income---2.7M-4.7M-3.9M
 
 
 
 
General Expenses8.0M9.0M13.6M8.3M
 
 
 
 
 
Research And Development3.4M5.2M9.7M5.2M
 
 
 
 
 
Total Operating Expenses8.0M12.0M18.5M12.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.8M-11.7M-18.3M-12.2M
 
 
 
 
 
Extraordinary Charge---892.0K-2.2M0.00
 
 
 
Other Expenses609.9K477.3K2.3M-205.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.9M-11.5M-18.0M-12.2M
 
 
 
 
 
Income Taxes-417.1K-1.9M0.00-7.9M
 
 
 
 
Net Income-6.5M-9.6M-18.0M-4.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.6M5.8M7.2M8.9M
 
 
 
 
 
Shares To Calculate EPS Diluted4.6M5.8M7.2M8.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.42-$1.64-$2.51-$0.48
 
 
 
 
 
EPS Diluted-$1.42-$1.64-$2.51-$0.48